AI and Healthcare

Patients, data, and profits—with Dr. Sanjay Juneja

Dr. Sanjay Juneja and Dr. Debra Patt discuss patient data in healthcare, including de-identification, data aggregation for research, and the evolving role of AI. They explore how communication systems and real-world evidence improve care delivery, reduce ER visits, and enhance efficiency for healthcare providers.

Why Is The Drug Discovery Market So Slow?—with Mika Newton

Mika Newton and Tom Neyarapally discuss how advancements in data, AI tools, and computing power are transforming drug discovery, particularly in oncology. They explore patient-centric approaches, in silico screening, and strategies to reduce the time and cost of bringing new treatments to market.

Insights from the Chair of the ASCO AI Taskforce—with Dr. Sanjay Juneja

An overview of ASCO's approach to artificial intelligence in cancer care, focusing on responsible use, transparency, and the importance of keeping physicians at the center of decision-making. The clip discusses guidelines, challenges like biases and model limitations, and how AI can complement personalized care.

How is AI Helping Healthcare Providers Today?—with Dr. Sanjay Juneja

Dr. Debra Patt and Dr. Sanjay Juneja explore how AI is reshaping healthcare, focusing on its impact on physicians and patient care. Discover how AI tools are seamlessly integrated into care delivery, from enhancing cancer diagnostics and automating clinical documentation to improving administrative efficiency. Learn about AI-powered scribe services that reduce doctors’ workloads, enabling real-time patient notes, better disease management, and enhanced communication with caregivers. Additionally, we explore AI's role in drug discovery, clinical trial optimization, and streamlining insurance approvals.

How Can AI Help Reduce The Financial Burden Of The Healthcare System?—with Dr. Sanjay Juneja

Dr. Juneja and Dr. Patt discuss the financial implications of AI adoption, how tools like ambient listening and real-time monitoring can enhance patient care, and the role of AI in educating patients to manage treatment toxicities. Plus, they dive into the advancements in drug discovery and clinical trials, where AI is paving the way for more efficient and personalized therapies.

From Targeting Cancer to Transforming Care: Introducing AI and Healthcare

In this episode, Dr. Sanjay Juneja is joined by Mika Newton, CEO of xCures, to explore how AI is transforming the future of medicine. Together, they discuss tackling critical challenges like resource shortages, improving patient triaging, and leveraging data for smarter, faster decision-making. Mika shares his unique insights on how technology is reshaping healthcare systems and the exciting opportunities ahead. Don’t miss this engaging conversation —and stay tuned for a surprising reveal at the end!

Steroids and Hormones in Cancer Care with Dr. Afreen Shariff

Join Dr. Sanjay Juneja, known as the OncDoc, as he discusses the complex intersection of endocrinology and oncology with Dr. Afreen Shariff, an expert endo-oncologist from Duke University. This episode explores the often-overlooked endocrine side effects of cancer treatments, such as steroids and immune therapies, and how they impact patient quality of life. Dr. Shariff shares insights on managing hormonal imbalances, the importance of specialized care, and how platforms like Citrus Oncology are democratizing access to expert opinions and care. Discover how patients can better navigate the challenges of cancer treatment and thrive, supported by comprehensive, multi-specialty care. If you or a loved one are facing cancer treatment, this episode is essential listening.

AI's Role in Predicting Cancer Treatment Outcomes with Dr. Tim Showalter

In this episode of the Target Cancer Podcast, Dr. Sanjay Juneja sits down with Dr. Tim Showalter, Chief Medical Officer at Artera, to explore the transformative role of AI in personalizing cancer treatment. Dr. Showalter shares insights on how advanced AI tools are helping clinicians make more precise decisions, reducing overtreatment, and improving patients’ quality of life. Together, they discuss the moral and medical challenges of balancing aggressive cancer therapies with patient-centered care and the promise of AI in guiding better, data-driven outcomes.